Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patients

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

(2012) Rafael Rosell et al.   LANCET ONCOLOGY

Clinical Upstaging of Non-Small Cell Lung Cancer That Extends Across the Fissure: Implications for Non-Small Cell Lung Cancer Staging

(2011) Vijay Joshi et al.   ANNALS OF THORACIC SURGERY

Non-small cell lung cancer in never smokers: a clinical entity to be identified

(2011) Ilka Lopes Santoro et al.   Clinics

Node-Negative Non-small Cell Lung Cancer: Pathological Staging and Survival in 1765 Consecutive Cases

(2011) Benjamin M. Robinson et al.   Journal of Thoracic Oncology

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

(2011) Caicun Zhou et al.   LANCET ONCOLOGY

Epidemiology of Lung Cancer: Smoking, Secondhand Smoke, and Genetics

(2011) Matthew A. Steliga et al.   Surgical Oncology Clinics of North America

Should we operate on microscopic N2 non-small cell lung cancer?

(2011) E. Fontaine et al.   Interactive Cardiovascular and Thoracic Surgery

Survival Comparison of Adenosquamous, Squamous Cell, and Adenocarcinoma of the Lung After Lobectomy

(2010) David T. Cooke et al.   ANNALS OF THORACIC SURGERY

Long-term Survival Outcomes by Smoking Status in Surgical and Nonsurgical Patients With Non-small Cell Lung Cancer

(2010) Robert A. Meguid et al.   CHEST

The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer

(2010) Kari Chansky et al.   Journal of Thoracic Oncology

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

(2010) Federico Cappuzzo et al.   LANCET ONCOLOGY

Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer

(2009) Yelena Y. Janjigian et al.   CANCER